{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:20:01Z","timestamp":1790778001135,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In Egypt, where bilharziasis is endemic, bladder cancer is the commonest cancer in males and the 2<jats:sup>nd<\/jats:sup> in females; squamous cell carcinoma (SCC) is the commonest type found, with a peculiar mode of presentation. The aim of this study is to identify and rank the risk factors of muscle invasive bladder cancer (MIBC) in Upper Egypt and describe its specific criteria of presentation and histopathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is an analytical, hospital based, case controlled study conducted in south Egypt cancer institute through comparing MIBC cases (n = 130) with age, sex and residence matched controls (n = 260) for the presence of risk factors of MIBC. Data was collected by personal interview using a well designed questionnaire. Patients' records were reviewed for histopathology and Radiologic findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The risk factors of MIBC were positive family history [Adjusted odds ratio (AOR) = 7.7], exposure to pesticides [AOR = 6.2], bladder stones [AOR = 5], consanguinity [AOR = 3.9], recurrent cystitis [AOR = 3.1], bilharziasis [odds ratio (OR) = 5.8] and smoking [OR = 5.3]. SCC represented 67.6% of cases with burning micturition being the presenting symptom in 73.8%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>MIBC in Upper Egypt is usually of the SCC type (although its percentage is decreasing), occurs at a younger age and presents with burning micturition rather than hematuria. Unlike the common belief, positive family history, parents' consanguinity, exposure to pesticides and chronic cystitis seem to play now more important roles than bilharziasis and smoking in the development of this disease in this area.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-250","type":"journal-article","created":{"date-parts":[[2008,8,30]],"date-time":"2008-08-30T06:13:00Z","timestamp":1220076780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics"],"prefix":"10.1186","volume":"8","author":[{"given":"Ali H","family":"Zarzour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohie","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A","family":"Abd-Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa A","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A","family":"AbdelAziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"1188_CR1","volume-title":"Cancer Facts & Figures 2007","author":"American cancer society","year":"2007","unstructured":"American cancer society: Cancer Facts & Figures 2007. 2007, Atlanta: American cancer society, [http:\/\/www.cancer.org\/downloads\/STT\/CAFF2007PWSecured.pdf]"},{"key":"1188_CR2","unstructured":"Public health impact of schistosomiasis: disease and mortality. WHO Expert Committee on the Control of Schistosomiasis. Bull World Health Organ. 1993, 71 (6): 657-662."},{"issue":"3","key":"1188_CR3","first-page":"127","volume":"17","author":"HM Khaled","year":"2005","unstructured":"Khaled HM: Systemic management of bladder cancer in Egypt: revisited; as well as: Expert Opin Investig Drugs. J Egypt Natl Canc Inst. 2005, 17 (3): 127-31.","journal-title":"J Egypt Natl Canc Inst"},{"key":"1188_CR4","first-page":"28","volume-title":"Epidemiology of bladder cancer and ligand binding","author":"SI Amal","year":"1983","unstructured":"Amal SI, El-Sebai I: Epidemiology of bladder cancer and ligand binding. 1983, Cancer bladder, Inc Florida Press, 1: 28-32."},{"key":"1188_CR5","volume-title":"Detailed guide: bladder cancer","author":"American cancer society","year":"2006","unstructured":"American cancer society: Detailed guide: bladder cancer. 2006, [http:\/\/www.cancer.org\/docroot\/CRI\/content\/CRI_2_4_2X_What_are_the_risk_factors_for_bladder_cancer_44.asp]"},{"issue":"1","key":"1188_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00139709-200322010-00005","volume":"22","author":"TT Mensing","year":"2003","unstructured":"Mensing TT, Speijers GJ, Meulenbelt J: Health implications of exposure to environmental nitrogenous compounds. Toxicol Rev. 2003, 22 (1): 41-51. 10.2165\/00139709-200322010-00005.","journal-title":"Toxicol Rev"},{"issue":"2","key":"1188_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0165-4608(01)00576-3","volume":"133","author":"LR Webster","year":"2002","unstructured":"Webster LR, McKenzie GH, Moriarty HT: Organophosphate based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet. 2002, 133 (2): 112-117. 10.1016\/S0165-4608(01)00576-3.","journal-title":"Cancer Genet Cytogenet"},{"issue":"31","key":"1188_CR8","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1200\/JCO.2007.10.7557","volume":"25","author":"Xifeng Wu","year":"2007","unstructured":"Wu Xifeng, Jie Lin H, Grossman Barton, Huang Maosheng, Gu Jian, Carol J, Etzel Amos CI, Dinney CP, Spitz MR: Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals. Journal of Clinical Oncology. 2007, 25 (31): 4974-4981. 10.1200\/JCO.2007.10.7557.","journal-title":"Journal of Clinical Oncology"},{"key":"1188_CR9","first-page":"435","volume":"1","author":"H LaRue","year":"1995","unstructured":"LaRue H, Simoneau M, Fradet Y: Human papilloma virus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res. 1995, 1: 435-438.","journal-title":"Clin Cancer Res"},{"key":"1188_CR10","first-page":"57","volume":"7","author":"MN El-Bolkainy","year":"2005","unstructured":"El-Bolkainy MN, Akram Nouh M, El-Bolkainy T: Cancer of urinary tract. Topographic Pathology of Cancer. 2005, 7: 57-64. 3","journal-title":"Topographic Pathology of Cancer"},{"issue":"1 Suppl","key":"1188_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T","volume":"1;75","author":"CF Lynch","year":"1995","unstructured":"Lynch CF, Cohen MB: Urinary system. Cancer. 1995, 1;75 (1 Suppl): 316-329. 10.1002\/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T.","journal-title":"Cancer"},{"key":"1188_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/sonc.2001.21961","volume":"28","author":"NG El-Mawla","year":"2001","unstructured":"El-Mawla NG, EL-Bolkainy MN, Khaled HM: Bladder cancer in Africa: update. Semin Oncol. 2001, 28: 174-178. 10.1053\/sonc.2001.21961.","journal-title":"Semin Oncol"},{"key":"1188_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(17)39853-1","volume":"143","author":"HT Lynch","year":"1990","unstructured":"Lynch HT, Ens JA, Lynch JF: The Lynch syndrome II and urological malignancies. J Urol. 1990, 143: 24-27.","journal-title":"J Urol"},{"key":"1188_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.12.1.97","volume":"12","author":"MH Mostafa","year":"1999","unstructured":"Mostafa MH, Sheweita SA, O'Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999, 12: 97-111.","journal-title":"Clin Microbiol Rev"},{"key":"1188_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jnci\/61.1.13","volume":"61","author":"AW Cheever","year":"1978","unstructured":"Cheever AW: Schistosomiasis and neoplasia. J Natl Cancer Inst. 1978, 61: 13-18.","journal-title":"J Natl Cancer Inst"},{"key":"1188_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00008469-199502000-00004","volume":"4","author":"AF Badawi","year":"1995","unstructured":"Badawi AF, Mostafa MH, Probert A, O'Connor PJ: Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev. 1995, 4: 45-59. 10.1097\/00008469-199502000-00004.","journal-title":"Eur J Cancer Prev"},{"key":"1188_CR17","volume-title":"Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER","author":"AS Ibrahim","year":"2006","unstructured":"Ibrahim AS, Khaled HM: Urinary Bladder Cancer. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. 2006, National Cancer Institute, NIH Pub. No. 06-5873. Bethesda, MD, [http:\/\/seer.cancer.gov\/publications\/mecc\/mecc_bladder.pdf]"},{"key":"1188_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2964(79)90039-2","volume":"15","author":"MM Merzabani","year":"1979","unstructured":"Merzabani MM, El-Aaser AA: Etiological factors of bilharzial bladder cancer in Egypt: nitrosamines and their precursors in urine. Eur J Cancer. 1979, 15: 287-291.","journal-title":"Eur J Cancer"},{"key":"1188_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.2910440411","volume":"44","author":"JD Burch","year":"1989","unstructured":"Burch JD, Rohan TE, Howe GR, Risch HA, Hill GP, Steel R, Miller AB: Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer. 1989, 44: 622-626. 10.1002\/ijc.2910440411.","journal-title":"Int J Cancer"},{"key":"1188_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2298\/VSP0302195R","volume":"60","author":"V Radosavljevic","year":"2003","unstructured":"Radosavljevic V, Ilic M, Jankovic S: Epidemiology and risk factors for the onset of urinary bladder cancer. Vojnosanit Pregl. 2003, 60: 195-201.","journal-title":"Vojnosanit Pregl"},{"issue":"4","key":"1188_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10552-007-9104-7","volume":"19","author":"AS Felix","year":"2008","unstructured":"Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML: The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control. 2008, 19 (4): 421-9. 10.1007\/s10552-007-9104-7.","journal-title":"Cancer Causes Control"},{"key":"1188_CR22","first-page":"2643","volume":"48","author":"MN El-Bolkainy","year":"1981","unstructured":"El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH: The impact of schistosomiasis on the pathology of bladder carcinoma. Int J Cancer. 1981, 48: 2643-2651.","journal-title":"Int J Cancer"},{"issue":"1","key":"1188_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.juro.2008.03.024","volume":"180","author":"MA Ghoneim","year":"2008","unstructured":"Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, El-Baz MA: Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008, 180 (1): 121-7. 10.1016\/j.juro.2008.03.024.","journal-title":"J Urol"},{"key":"1188_CR24","first-page":"1396","volume-title":"Principles and practice of oncology","author":"HW Herr","year":"2001","unstructured":"Herr HW, Shipley WU, Bajorin DF: Cancer of the bladder. Principles and practice of oncology. 2001, Philadelphia, Williams and Wilkins press, 1396-1401. 6","edition":"6"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10147-004-0457-6","volume":"10","author":"M El-Sebaie","year":"2005","unstructured":"El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A: Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol. 2005, 10: 20-25. 10.1007\/s10147-004-0457-6.","journal-title":"Int J Clin Oncol"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0022-5347(01)64487-2","volume":"158","author":"MA Ghoneim","year":"1997","unstructured":"Ghoneim MA, El-Makresh MM, El-Baz MA, El-Attar IA, Ashamallah A: Radical cystectomy for carcinoma of the bladder. Critical evaluation of the results in 1026 cases. J Urol. 1997, 158: 393-399. 10.1016\/S0022-5347(01)64487-2.","journal-title":"J Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-250\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:26:39Z","timestamp":1630463199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,29]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-250","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,29]]},"assertion":[{"value":"29 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"250"}}